Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab (Q81334004)
Jump to navigation
Jump to search
scientific article published on 01 February 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab |
scientific article published on 01 February 2005 |
Statements
Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab (English)
Nikos Markomichelakis
George P Theodossiadis
Vlassis Grigoropoulos
Nikos Katsilambros
Panayiotis G Theodossiadis
1 February 2005